 | • レポートコード：MRC2102QY0768 • 出版社/出版日：QYResearch / 2021年1月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の抗消化性潰瘍治療薬市場について種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、潰瘍保護薬）、用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗消化性潰瘍治療薬市場の概要 ・世界の主要地域別抗消化性潰瘍治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗消化性潰瘍治療薬市場規模2015-2026：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、潰瘍保護薬） ・世界の抗消化性潰瘍治療薬市場規模2015-2026：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍治療薬の米国市場規模2015-2020 ・抗消化性潰瘍治療薬のヨーロッパ市場規模2015-2020 ・抗消化性潰瘍治療薬の中国市場規模2015-2020 ・抗消化性潰瘍治療薬の日本市場規模2015-2020 ・抗消化性潰瘍治療薬の東南アジア市場規模2015-2020 ・抗消化性潰瘍治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・抗消化性潰瘍治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗消化性潰瘍治療薬の市場動向・機会・課題 ・調査の結論 |
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
China’s anti-trust crackdown on foreign pharmaceutical companies has left many foreign investors in the healthcare industry shocked. The Chinese government has had no qualms about openly stating that it prefers hospitals to purchase from domestic producers. That said, China’s homegrown manufacturers of medical devices and medicine still lack the sophistication to produce many of the more advanced health care products the country needs. Amid rising living standards and an aging population, China’s healthcare needs are set to rise sharply in the coming years.
Market Analysis and Insights: Global Anti-Peptic Ulcer Drugs Market
The global Anti-Peptic Ulcer Drugs market size is projected to reach US$ 16340 million by 2026, from US$ 7691.6 million in 2020, at a CAGR of 13.4% during 2021-2026.
Global Anti-Peptic Ulcer Drugs Scope and Market Size
The global Anti-Peptic Ulcer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Peptic Ulcer Drugs market is segmented into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Segment by Application, the Anti-Peptic Ulcer Drugs market is segmented into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
The Anti-Peptic Ulcer Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Peptic Ulcer Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Peptic Ulcer Drugs Market Share Analysis
Anti-Peptic Ulcer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Peptic Ulcer Drugs business, the date to enter into the Anti-Peptic Ulcer Drugs market, Anti-Peptic Ulcer Drugs product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
1 Anti-Peptic Ulcer Drugs Market Overview
1.1 Anti-Peptic Ulcer Drugs Product Scope
1.2 Anti-Peptic Ulcer Drugs Segment by Type
1.2.1 Global Anti-Peptic Ulcer Drugs Sales by Type (2020-2026)
1.2.2 Proton Pump Inhibitors (PPIs)
1.2.3 Potassium-Competitive Acid Blockers (P-CAB)
1.2.4 Antacids
1.2.5 H2 Antagonists
1.2.6 Ulcer Protective Drugs
1.3 Anti-Peptic Ulcer Drugs Segment by Application
1.3.1 Global Anti-Peptic Ulcer Drugs Sales Comparison by Application (2020-2026)
1.3.2 Gastritis
1.3.3 Gastric Ulcers
1.3.4 Duodenal Ulcers
1.3.5 Gastroesophageal Reflux Disease (GERD)
1.4 Anti-Peptic Ulcer Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anti-Peptic Ulcer Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Anti-Peptic Ulcer Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Anti-Peptic Ulcer Drugs Price Trends (2015-2026)
2 Anti-Peptic Ulcer Drugs Estimate and Forecast by Region
2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anti-Peptic Ulcer Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anti-Peptic Ulcer Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
2.4.3 China Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
2.4.6 India Anti-Peptic Ulcer Drugs Estimates and Projections (2015-2026)
3 Global Anti-Peptic Ulcer Drugs Competition Landscape by Players
3.1 Global Top Anti-Peptic Ulcer Drugs Players by Sales (2015-2020)
3.2 Global Top Anti-Peptic Ulcer Drugs Players by Revenue (2015-2020)
3.3 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2019)
3.4 Global Anti-Peptic Ulcer Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Anti-Peptic Ulcer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anti-Peptic Ulcer Drugs Players (Opinion Leaders)
4 Global Anti-Peptic Ulcer Drugs Market Size by Type
4.1 Global Anti-Peptic Ulcer Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Anti-Peptic Ulcer Drugs Price by Type (2015-2020)
4.2 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Anti-Peptic Ulcer Drugs Price Forecast by Type (2021-2026)
5 Global Anti-Peptic Ulcer Drugs Market Size by Application
5.1 Global Anti-Peptic Ulcer Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Anti-Peptic Ulcer Drugs Price by Application (2015-2020)
5.2 Global Anti-Peptic Ulcer Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anti-Peptic Ulcer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Peptic Ulcer Drugs Price Forecast by Application (2021-2026)
6 United States Anti-Peptic Ulcer Drugs Market Facts & Figures
6.1 United States Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
6.2 United States Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
6.3 United States Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
7 Europe Anti-Peptic Ulcer Drugs Market Facts & Figures
7.1 Europe Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
8 China Anti-Peptic Ulcer Drugs Market Facts & Figures
8.1 China Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
8.2 China Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
8.3 China Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
9 Japan Anti-Peptic Ulcer Drugs Market Facts & Figures
9.1 Japan Anti-Peptic Ulcer Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Anti-Peptic Ulcer Drugs Market Facts & Figures
10.1 Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
11 India Anti-Peptic Ulcer Drugs Market Facts & Figures
11.1 India Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
11.2 India Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
11.3 India Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anti-Peptic Ulcer Drugs Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Ask-pharm
12.2.1 Ask-pharm Corporation Information
12.2.2 Ask-pharm Business Overview
12.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Products Offered
12.2.5 Ask-pharm Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takeda Anti-Peptic Ulcer Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Yangtze River Pharm
12.4.1 Yangtze River Pharm Corporation Information
12.4.2 Yangtze River Pharm Business Overview
12.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Products Offered
12.4.5 Yangtze River Pharm Recent Development
12.5 Shandong Luoxin
12.5.1 Shandong Luoxin Corporation Information
12.5.2 Shandong Luoxin Business Overview
12.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Products Offered
12.5.5 Shandong Luoxin Recent Development
12.6 Huadong Medicine
12.6.1 Huadong Medicine Corporation Information
12.6.2 Huadong Medicine Business Overview
12.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Products Offered
12.6.5 Huadong Medicine Recent Development
12.7 Changzhou Siyao
12.7.1 Changzhou Siyao Corporation Information
12.7.2 Changzhou Siyao Business Overview
12.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Products Offered
12.7.5 Changzhou Siyao Recent Development
12.8 Beijing Yuekang
12.8.1 Beijing Yuekang Corporation Information
12.8.2 Beijing Yuekang Business Overview
12.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Products Offered
12.8.5 Beijing Yuekang Recent Development
12.9 Guangdong Dahua
12.9.1 Guangdong Dahua Corporation Information
12.9.2 Guangdong Dahua Business Overview
12.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Products Offered
12.9.5 Guangdong Dahua Recent Development
12.10 Xian Janssen
12.10.1 Xian Janssen Corporation Information
12.10.2 Xian Janssen Business Overview
12.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Products Offered
12.10.5 Xian Janssen Recent Development
13 Anti-Peptic Ulcer Drugs Manufacturing Cost Analysis
13.1 Anti-Peptic Ulcer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Peptic Ulcer Drugs
13.4 Anti-Peptic Ulcer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Peptic Ulcer Drugs Distributors List
14.3 Anti-Peptic Ulcer Drugs Customers
15 Market Dynamics
15.1 Anti-Peptic Ulcer Drugs Market Trends
15.2 Anti-Peptic Ulcer Drugs Opportunities and Drivers
15.3 Anti-Peptic Ulcer Drugs Market Challenges
15.4 Anti-Peptic Ulcer Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-Peptic Ulcer Drugs Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Anti-Peptic Ulcer Drugs Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Anti-Peptic Ulcer Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Anti-Peptic Ulcer Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Anti-Peptic Ulcer Drugs Revenue Share by Region (2015-2020)
Table 8. Global Anti-Peptic Ulcer Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Anti-Peptic Ulcer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Anti-Peptic Ulcer Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Anti-Peptic Ulcer Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Anti-Peptic Ulcer Drugs Sales Share by Company (2015-2020)
Table 14. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Anti-Peptic Ulcer Drugs Revenue Share by Company (2015-2020)
Table 16. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2019)
Table 17. Global Anti-Peptic Ulcer Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Anti-Peptic Ulcer Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Peptic Ulcer Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Anti-Peptic Ulcer Drugs Players
Table 22. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2015-2020)
Table 24. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Anti-Peptic Ulcer Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Anti-Peptic Ulcer Drugs Sales Share by Type (2021-2026)
Table 27. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2021-2026)
Table 29. Global Anti-Peptic Ulcer Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2015-2020)
Table 32. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Anti-Peptic Ulcer Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Anti-Peptic Ulcer Drugs Sales Share by Application (2021-2026)
Table 36. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2021-2026)
Table 38. Global Anti-Peptic Ulcer Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 51. China Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 53. China Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 55. China Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 69. India Anti-Peptic Ulcer Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Anti-Peptic Ulcer Drugs Sales Market Share by Company (2015-2020)
Table 71. India Anti-Peptic Ulcer Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Anti-Peptic Ulcer Drugs Sales Market Share by Type (2015-2020)
Table 73. India Anti-Peptic Ulcer Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Anti-Peptic Ulcer Drugs Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. AstraZeneca Anti-Peptic Ulcer Drugs Product
Table 79. AstraZeneca Recent Development
Table 80. Ask-pharm Corporation Information
Table 81. Ask-pharm Description and Business Overview
Table 82. Ask-pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Ask-pharm Anti-Peptic Ulcer Drugs Product
Table 84. Ask-pharm Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Takeda Anti-Peptic Ulcer Drugs Product
Table 89. Takeda Recent Development
Table 90. Yangtze River Pharm Corporation Information
Table 91. Yangtze River Pharm Description and Business Overview
Table 92. Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product
Table 94. Yangtze River Pharm Recent Development
Table 95. Shandong Luoxin Corporation Information
Table 96. Shandong Luoxin Description and Business Overview
Table 97. Shandong Luoxin Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Shandong Luoxin Anti-Peptic Ulcer Drugs Product
Table 99. Shandong Luoxin Recent Development
Table 100. Huadong Medicine Corporation Information
Table 101. Huadong Medicine Description and Business Overview
Table 102. Huadong Medicine Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Huadong Medicine Anti-Peptic Ulcer Drugs Product
Table 104. Huadong Medicine Recent Development
Table 105. Changzhou Siyao Corporation Information
Table 106. Changzhou Siyao Description and Business Overview
Table 107. Changzhou Siyao Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Changzhou Siyao Anti-Peptic Ulcer Drugs Product
Table 109. Changzhou Siyao Recent Development
Table 110. Beijing Yuekang Corporation Information
Table 111. Beijing Yuekang Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Beijing Yuekang Description and Business Overview
Table 113. Beijing Yuekang Anti-Peptic Ulcer Drugs Product
Table 114. Beijing Yuekang Recent Development
Table 115. Guangdong Dahua Corporation Information
Table 116. Guangdong Dahua Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Guangdong Dahua Description and Business Overview
Table 118. Guangdong Dahua Anti-Peptic Ulcer Drugs Product
Table 119. Guangdong Dahua Recent Development
Table 120. Xian Janssen Corporation Information
Table 121. Xian Janssen Description and Business Overview
Table 122. Xian Janssen Anti-Peptic Ulcer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Xian Janssen Anti-Peptic Ulcer Drugs Product
Table 124. Xian Janssen Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Anti-Peptic Ulcer Drugs Distributors List
Table 128. Anti-Peptic Ulcer Drugs Customers List
Table 129. Anti-Peptic Ulcer Drugs Market Key Trends
Table 130. Anti-Peptic Ulcer Drugs Key Opportunities and Drivers
Table 131. Anti-Peptic Ulcer Drugs Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Product Picture
Figure 2. Global Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-Peptic Ulcer Drugs Market Share by Application in 2020 & 2026
Figure 6. Gastritis Examples
Figure 7. Gastric Ulcers Examples
Figure 8. Duodenal Ulcers Examples
Figure 9. Gastroesophageal Reflux Disease (GERD) Examples
Figure 10. Global Anti-Peptic Ulcer Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Anti-Peptic Ulcer Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Anti-Peptic Ulcer Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Anti-Peptic Ulcer Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Anti-Peptic Ulcer Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Anti-Peptic Ulcer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Anti-Peptic Ulcer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Anti-Peptic Ulcer Drugs Players Market Share by Revenue in Anti-Peptic Ulcer Drugs 2015 & 2019
Figure 28. Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Anti-Peptic Ulcer Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Anti-Peptic Ulcer Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Anti-Peptic Ulcer Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Anti-Peptic Ulcer Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 34. United States Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 35. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019
Figure 36. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 37. Europe Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 38. China Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019
Figure 39. China Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 40. China Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 41. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019
Figure 42. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 43. Japan Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 47. India Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019
Figure 48. India Anti-Peptic Ulcer Drugs Sales Market Share by Type in 2019
Figure 49. India Anti-Peptic Ulcer Drugs Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Anti-Peptic Ulcer Drugs
Figure 52. Manufacturing Process Analysis of Anti-Peptic Ulcer Drugs
Figure 53. Anti-Peptic Ulcer Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
抗潰瘍治療薬の世界市場レポート2020 Market Analysis and Insights: Global Anti-ulcer Drug Market The global Anti-ulcer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti-ulcer Drug Scope and Market Size The global Anti-ulcer Drug market is segmented…- 非ステロイド性抗炎症薬（NSAID）の世界市場レポート2020 Market Analysis and Insights: Global Non-steroidal Anti-inflammatory Drugs（NSAID） Market The global Non-steroidal Anti-inflammatory Drugs（NSAID） market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Non-steroidal Anti-inflamm…
- 褥瘡治療用品の世界市場レポート2020 Pressure ulcer is an open wound on the skin. Pressure ulcer occurs due to the breakdown of skin and underlying tissues through excessive pressure on an area of the skin. Some of the symptoms of pressure ulcer are redness of the skin that worsens with time, and blisters on the area and then an open s…
- 海洋由来薬品の世界市場レポート2020 Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydroph…
- ドライアイ治療薬の世界市場レポート2020 Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and contin…